ConductScience.org, home

Paper · 322367

Idiotypes as variable region markers: analogies between receptors on phosphorylcholine-specific T and B lymphocytes.

Cosenza H and 2 others. Immunol Rev, 1977. Cited by 166 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Idiotypes as variable region markers: analogies between receptors on phosphorylcholine-specific T and B lymphocytes. Papers, record 322367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/322367

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Idiotypes as variable region markers: analogies between receptors on phosphorylcholine-specific T and B lymphocytes.
PubMed
Journal
Immunol Rev
PubMed
Year
1977
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
166
iCite
Relative citation ratio, by iCite
3.87
iCite
Revised in PubMed
2021-12-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cosenza HH
2Julius MHM H
3Augustin AAA A

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B-LymphocytesMajor topic
Binding Sites, AntibodyMajor topic
CholineMajor topic
Immunoglobulin Variable RegionMajor topic
PhosphorylcholineMajor topic
T-LymphocytesMajor topic
Animals
Animals, Newborn
Autoantibodies
Female
Haptens
Immunity, Cellular
Immunosuppression Therapy
Maternal-Fetal Exchange
Mice
Mice, Inbred BALB C
Pregnancy
Spleen

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.

PMIDTitleJournalYearIn PapersSource
22,457,936Genetics of the anti-dextran B512 and the autoanti-idiotypic response: codominant expression in F1 hybrids and dichotomy of response and allotype-linked idiotype.Immunogenetics1980https://conductscience.org/library/papers/22457936PubMed
7,049,456The assessment of anti-idiopathic antibodies as effective immunoregulatory probes in vivo.Clin Exp Immunol1982https://conductscience.org/library/papers/7049456PubMed
7,031,652Suppression of a "recurrent" idiotype results in profound alterations of the whole B-cell compartment.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/7031652PubMed
7,028,912Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. II. Transient idiotypic dominance.J Exp Med1981https://conductscience.org/library/papers/7028912PubMed
7,014,422Inheritance patterns of idiotype expression: maternal-fetal immune regulatory networks.Immunogenetics1981https://conductscience.org/library/papers/7014422PubMed
6,985,352Recurrent idiotopes and internal images.EMBO J1982https://conductscience.org/library/papers/6985352PubMed
6,972,994Generation of idiotype-specific T cell help through network perturbation.J Exp Med1981https://conductscience.org/library/papers/6972994PubMed
6,968,810Late clonal selection and expansion of the TEPC-15 germ-line specificity.J Exp Med1980https://conductscience.org/library/papers/6968810PubMed
6,966,320Selective suppression of the major idiotypic component of an antihapten response by soluble T cell-derived factors with idiotypic or anti-idiotypic receptors.J Exp Med1980https://conductscience.org/library/papers/6966320PubMed
6,854,211Regulation of natural antiallotype antibody responses by idiotype network-induced auto-antiidiotypic antibodies.J Exp Med1983https://conductscience.org/library/papers/6854211PubMed

1 to 10 of 50

See all 50 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/322367

GET https://conductscience.org/api/papers/v1/322367/cited_by?page=2